| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Israel | 7 | |
| #2 | EPO (European Patent Office) | 5 | |
| #3 | United States | 5 | |
| #4 | WIPO (World Intellectual Property Organization) | 5 | |
| #5 | Brazil | 3 | |
| #6 | Canada | 3 | |
| #7 | Australia | 1 | |
| #8 | Taiwan | 1 | |
| #9 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Baichwal Anand R | 15 |
| #2 | Mccall Troy W | 13 |
| #3 | Kao Huai-Hung | 8 |
| #4 | Baichwal Anand | 5 |
| #5 | Ketsela Sara | 4 |
| #6 | Liu Lirong | 4 |
| #7 | Shlyankevich Alex | 4 |
| #8 | Sanghvi Pradeep P | 3 |
| #9 | Woodcock Paul M | 3 |
| #10 | Labudzinski Steve | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2004012715A1 | Sustained release formulations of metformin | |
| EP1429730A2 | Opioid formulations having reduced potential for abuse | |
| ZA200301851B | Sustained release formulations of oxymorphone. | |
| EP1404332A1 | Methods of making sustained release formulations of oxymorphone related applications | |
| TWI227144B | Sustained release matrix systems for highly soluble drugs |